resveratrol has been researched along with Amyloid Neuropathy Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, S; Connelly, S; Johnson, SM; Kelly, JW; Mortenson, DE; Powers, ET; Wilson, IA | 1 |
| Fujiwara, S; Kusaka, K; Mizuguchi, M; Nabeshima, Y; Yokoyama, T | 1 |
2 other study(ies) available for resveratrol and Amyloid Neuropathy Type 1
| Article | Year |
|---|---|
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
Topics: Amyloid Neuropathies, Familial; Computer Simulation; Drug Design; Humans; Molecular Docking Simulation; Prealbumin; Protein Multimerization; Protein Stability; Small Molecule Libraries | 2017 |
Resveratrol Derivatives Inhibit Transthyretin Fibrillization: Structural Insights into the Interactions between Resveratrol Derivatives and Transthyretin.
Topics: Amyloid; Amyloid Neuropathies, Familial; Amyloidosis; Crystallography, X-Ray; Humans; Prealbumin; Resveratrol | 2023 |